Two Sigma Investments Portfolio holdings
AUM
$55.5B
1-Year Return
27.18%
This Quarter Return
+6.54%
1 Year Return
+27.18%
3 Year Return
+82.36%
5 Year Return
+135.75%
10 Year Return
+365.6%
AUM
$37.4B
AUM Growth
+$3.67B
(+11%)
Cap. Flow
+$1.36B
Cap. Flow
% of AUM
3.64%
Top 10 Holdings %
Top 10 Hldgs %
8.07%
Holding
3,366
New
498
Increased
1,119
Reduced
1,084
Closed
464
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$351M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$339M |
| 3 |
NVIDIA
NVDA
|
+$266M |
| 4 |
Nike
NKE
|
+$237M |
| 5 |
Apple
AAPL
|
+$195M |
Top Sells
| 1 |
Netflix
NFLX
|
+$285M |
| 2 |
PCGU
PG&E Corporation
PCGU
|
+$221M |
| 3 |
Amazon
AMZN
|
+$188M |
| 4 |
ConocoPhillips
COP
|
+$186M |
| 5 |
Cigna
CI
|
+$171M |
Sector Composition
| 1 | Technology | 15.71% |
| 2 | Healthcare | 14.72% |
| 3 | Consumer Discretionary | 13.66% |
| 4 | Industrials | 11.89% |
| 5 | Financials | 10.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Latham Group
SWIM
$922M
| $132K | ﹤0.01% |
35,600
-14,200
| -29% | -$52.7K |
|
|
RPT
2602
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $132K | ﹤0.01% |
12,600
-5,200
| -29% | -$54.3K |
|
|
IMTXW
2603
DELISTED
Immatics N.V. Warrants
IMTXW
| $131K | ﹤0.01% |
+38,300
| New | +$131K |
|
|
DX
2604
Dynex Capital
DX
$1.68B
| $130K | ﹤0.01% |
10,300
-3,800
| -27% | -$47.8K |
|
2605
Acumen Pharmaceuticals
ABOS
$87.2M
| $128K | ﹤0.01% |
26,635
-27,447
| -51% | -$132K |
|
|
BORR
2606
Borr Drilling
BORR
$870M
| $128K | ﹤0.01% |
17,000
-71,696
| -81% | -$540K |
|
2607
Horizon Technology Finance
HRZN
$291M
| $127K | ﹤0.01% |
+10,527
| New | +$127K |
|
2608
Spero Therapeutics
SPRO
$111M
| $123K | ﹤0.01% |
84,535
+52,435
| +163% | +$76K |
|
2609
Udemy
UDMY
$1.03B
| $121K | ﹤0.01% |
11,300
-1,200
| -10% | -$12.9K |
|
2610
Apyx Medical
APYX
$77.9M
| $120K | ﹤0.01% |
23,900
+5,100
| +27% | +$25.7K |
|
2611
Fennec Pharmaceuticals
FENC
$257M
| $120K | ﹤0.01% |
13,561
-46,809
| -78% | -$413K |
|
2612
Precigen
PGEN
$1.23B
| $120K | ﹤0.01% |
104,000
-84,500
| -45% | -$97.2K |
|
|
CMLS
2613
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $118K | ﹤0.01% |
+28,846
| New | +$118K |
|
|
MIR.WS
2614
DELISTED
Mirion Technologies, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MIR.WS
| $117K | ﹤0.01% |
64,200
| – | – |
|
2615
Lineage Cell Therapeutics
LCTX
$290M
| $115K | ﹤0.01% |
81,816
+56,510
| +223% | +$79.7K |
|
|
CANO
2616
DELISTED
Cano Health, Inc.
CANO
| $115K | ﹤0.01% |
+830
| New | +$115K |
|
|
SOL
2617
Emeren Group
SOL
$96.5M
| $114K | ﹤0.01% |
+30,121
| New | +$114K |
|
2618
Absci
ABSI
$380M
| $113K | ﹤0.01% |
74,427
+22,746
| +44% | +$34.6K |
|
2619
GCM Grosvenor
GCMG
$678M
| $113K | ﹤0.01% |
+14,981
| New | +$113K |
|
|
QD
2620
Qudian
QD
$698M
| $112K | ﹤0.01% |
55,915
-47,284
| -46% | -$94.6K |
|
2621
Diana Shipping
DSX
$228M
| $111K | ﹤0.01% |
37,607
| – | – |
|
2622
Orion Group Holdings
ORN
$286M
| $110K | ﹤0.01% |
39,243
-1,300
| -3% | -$3.65K |
|
2623
SurgePays
SURG
$55.1M
| $110K | ﹤0.01% |
+15,085
| New | +$110K |
|
2624
Protalix BioTherapeutics
PLX
$137M
| $110K | ﹤0.01% |
55,125
-138,969
| -72% | -$278K |
|
2625
Inseego
INSG
$193M
| $109K | ﹤0.01% |
16,936
+5,669
| +50% | +$36.5K |
|